Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Social Capital Suvretta Holdings Corp. II (DNAB)

9.995   0.015 (0.15%) 12-05 15:06
Open: 9.98 Pre. Close: 9.98
High: 9.995 Low: 9.97
Volume: 9,114 Market Cap: 256(M)

Technical analysis

as of: 2022-12-06 8:47:46 AM
Overall:       
Stoxline posted a NEUTRAL today, upgraded from lower rating. Current trend continues, but could change at anytime. It is not a good time to buy or sell.
Target: Six months: 11.67     One year: 13.63
Support: Support1: 9.93    Support2: 9.89
Resistance: Resistance1: 9.99    Resistance2: 11.67
Pivot: 9.96
Moving Average: MA(5): 9.98     MA(20): 9.95
MA(100): 9.83     MA(250): 9.77
MACD: MACD(12,26): 0     Signal(9): 0
Stochastic oscillator: %K(14,3): 90.4     %D(3): 88.8
RSI: RSI(14): 71.9
52-week: High: 9.99  Low: 9.6
Average Vol(K): 3-Month: 94 (K)  10-Days: 22 (K)

Price, moving averages and Bollinger Bands

Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.
[ DNAB ] has closed below upper band by 15.0%. Bollinger Bands are 24.3% wider than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 10 - 10.05 10.05 - 10.09
Low: 9.85 - 9.91 9.91 - 9.96
Close: 9.91 - 10 10 - 10.07

Company Description

Social Capital Suvretta Holdings Corp. II does not have significant operations. It intends to effect a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses in biotechnology industry. The company was incorporated in 2021 and is based in Henderson, Nevada.

Headline News

Mon, 28 Nov 2022
SV40 T-antigen uses a DNA shearing mechanism to initiate origin unwinding | Proceedings of the National Academy of Sciences - pnas.org

Tue, 20 Sep 2022
More hard knocks for the blank cheque space - Evaluate Pharma

Mon, 11 Jul 2022
Akili Announces Public Company Board of Director Nominees - Business Wire

Wed, 26 Jan 2022
Chamath Palihapitiya Social Capital Survetta SPAC lands $1B merger deal with Akili - Silicon Valley Business Journal - The Business Journals

Mon, 10 Jan 2022
Still Waiting for a 2022 SPAC Deal as Capstar Sets Redemption Record - TheStreet

Thu, 16 Dec 2021
Saba Capital Management, L.P. Buys Digital World Acquisition Corp, Mudrick Capital Acquisition ... - Yahoo Finance

Financial Analysis

Price to Book Value: Outperform
P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly.
Price to Earnings: Outperform
PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS).
Discounted cash flow: Outperform
DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows.
Return on Assets: Neutral
ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit.
Return on Equity: Neutral
ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency.
Debt to Equity: Neutral
evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Financial Services
Industry:  Shell Companies
Shares Out. 26 (M)
Shares Float 23 (M)
% Held by Insiders 2.5 (%)
% Held by Institutions 96.5 (%)
Shares Short 158 (K)
Shares Short P.Month 95 (K)

Stock Financials

EPS 0
EPS Est Next Qtl 0
EPS Est This Year 0
EPS Est Next Year 0
Book Value (p.s.) -0.24
Profit Margin (%) 0
Operating Margin (%) 0
Return on Assets (ttm) 0
Return on Equity (ttm) 0
Qtrly Rev. Growth 0
Gross Profit (p.s.) 0
Sales Per Share 0
EBITDA (p.s.) 0
Qtrly Earnings Growth 0
Operating Cash Flow -1 (M)
Levered Free Cash Flow 0 (M)

Stock Valuations

PE Ratio 0
PEG Ratio 0
Price to Book value -43.46
Price to Sales 0
Price to Cash Flow -449.16

Stock Dividends

Dividend 0
Forward Dividend 0
Dividend Yield 0%
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
Your Ad Here
android_stock_chart
StockChart iOS
stoxline_lite
StoxlineLite iOS
stoxline_pro
StoxlineLite iOS
Option_Calculator
OptionCalc iOS
android_stock_chart
StockChart Android
stoxline_lite
StoxlineLite Android
stoxline_pro
StoxlinePro Android
Option_Calculator
OptionCalc Android
(c) 2006-2022 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.